Anne Samuel
Stock Analyst at JP Morgan
(1.83)
# 3,250
Out of 5,129 analysts
67
Total ratings
50%
Success rate
-2.61%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $2.67 | +162.17% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $76.90 | +63.85% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $177.04 | +63.80% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $21.55 | +16.01% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $25.96 | +131.12% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $177.18 | -0.10% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $37.82 | -4.81% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $12.50 | +124.00% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $26.88 | -21.88% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $1.99 | +553.27% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $23.73 | +13.78% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $1.69 | +195.86% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $2.67
Upside: +162.17%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $76.90
Upside: +63.85%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $177.04
Upside: +63.80%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $21.55
Upside: +16.01%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $25.96
Upside: +131.12%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $177.18
Upside: -0.10%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $37.82
Upside: -4.81%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $12.50
Upside: +124.00%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $26.88
Upside: -21.88%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $1.99
Upside: +553.27%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $23.73
Upside: +13.78%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $1.69
Upside: +195.86%